These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30677482)

  • 1. Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.
    Chvatal A; Ambrus R; Party P; Katona G; Jójárt-Laczkovich O; Szabó-Révész P; Fattal E; Tsapis N
    Int J Pharm; 2019 Mar; 559():68-75. PubMed ID: 30677482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements.
    Party P; Kókai D; Burián K; Nagy A; Hopp B; Ambrus R
    Eur J Pharm Sci; 2022 Sep; 176():106247. PubMed ID: 35760279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large porous particles for respiratory drug delivery. Glycine-based formulations.
    Ogienko AG; Bogdanova EG; Trofimov NA; Myz SA; Ogienko AA; Kolesov BA; Yunoshev AS; Zubikov NV; Manakov AY; Boldyrev VV; Boldyreva EV
    Eur J Pharm Sci; 2017 Dec; 110():148-156. PubMed ID: 28479348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone palmitate large porous particles: A controlled release formulation for lung delivery of corticosteroids.
    N'Guessan A; Fattal E; Chapron D; Gueutin C; Koffi A; Tsapis N
    Eur J Pharm Sci; 2018 Feb; 113():185-192. PubMed ID: 28890202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin.
    Kadota K; Yanagawa Y; Tachikawa T; Deki Y; Uchiyama H; Shirakawa Y; Tozuka Y
    Int J Pharm; 2019 Jan; 555():280-290. PubMed ID: 30471373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery.
    Silva AS; Sousa AM; Cabral RP; Silva MC; Costa C; Miguel SP; Bonifácio VDB; Casimiro T; Correia IJ; Aguiar-Ricardo A
    Int J Pharm; 2017 Mar; 519(1-2):240-249. PubMed ID: 28111281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S; Schoenbrodt T; Weiler C; Friess W
    Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB; Tucker IG; Das SC
    Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
    Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
    Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1321-1331. PubMed ID: 31014129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stability testing of meloxicam-containing microcomposites for inhalation].
    Pomázi A; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs.
    Tse JY; Koike A; Kadota K; Uchiyama H; Fujimori K; Tozuka Y
    Eur J Pharm Biopharm; 2021 Oct; 167():116-126. PubMed ID: 34363979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity.
    Ourique AF; Chaves Pdos S; Souto GD; Pohlmann AR; Guterres SS; Beck RC
    Eur J Pharm Sci; 2014 Dec; 65():174-82. PubMed ID: 25263567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray freeze drying for dry powder inhalation of nanoparticles.
    Ali ME; Lamprecht A
    Eur J Pharm Biopharm; 2014 Aug; 87(3):510-7. PubMed ID: 24657824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.
    Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.